SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs Q3 earnings and outlook dominate discussion, with traders focused on subscriber engagement and growth, ad revenue, and the effect of recent layoffs and content-leadership changes. Views are sharply divided: some see low expectations and a chance for a rebound, while others fear further weakness, citing the stocks decline and its recent post-earnings performance.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Speculation around a potential buyoutfueled by the CEOs anniversary message and the companys planned ASH presenceis competing with anticipation of a final analysis of SELLASs REGAL Phase 3 trial, last reported at 78 of 80 required events. Some traders read the prolonged trial and managements upbeat tone as encouraging, while others stress that no acquisition, event threshold, or trial result has been confirmed and that the recent price move may be trading without fresh news.

Sea Ltd. is an internet and mobile platform company, which engages in the provision of online gaming services. It operates through the following segments: Digital Entertainment, E-Commerce, and Digital Financial Services. The Digital Entertainment segment offers and develops mobile and PC online games. The E-Commerce segment manages a third-party marketplace through the Shopee mobile app and websites that connect buyers and sellers. The Digital Financial Services segment includes a variety of payment services and loans to individuals and businesses through SeaMoney. Sea was founded by Xiao Dong Li, Gang Ye, and Jing Ye Chen on May 8, 2009 and is headquartered in Singapore.

Sea Ltd - ADR

Seas plan to pursue a public listing for its Monee financial-services arm is fueling debate as shares sell off. Some traders see the separation and uncertain timeline as an overhang that could leave Sea with less valuable businesses, while others argue shareholders could benefit from receiving Monee shares or from the business being valued separately.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is drawing attention for persistent share-price underperformance despite growth in its commercial business, with many traders blaming weak confidence in management and the companys acquisition-focused strategy. The debate centers on debt and dilution concerns versus the potential of upcoming Navenibart and Netherton data to support the pipeline and restore confidence.

Myriad Genetics, Inc. is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. It develops and commercializes molecular tests that help patients and providers uncover genetic insights. The company was founded by Walter A. Gilbert, Mark H. Skolnick, and Peter D. Meldrum in May 1991 and is headquartered in Salt Lake City, UT.

Myriad Genetics, Inc.

Myriads agreement to sell its prenatal testing business to Labcorp has driven a sharp rally, with traders focused on the cash proceeds and potential balance-sheet and strategic benefits. The reaction is divided: some see a positive reset, while skeptics worry the divestiture removes a meaningful revenue business and leaves weaker operations and debt concerns.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GE is selling off despite a quarterly earnings beat and higher full-year guidance, as traders focus on rising costs, weaker cash conversion, lower-margin sales and a loss in its insurance business; some also worry that engines are accumulating at Boeing ahead of aircraft deliveries. The reaction has frustrated bullish traders who see strong demand and orders, while others view the selloff as evidence that profitability and execution matter more than the headline beat.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta is drawing attention as shares rebound while traders look ahead to clinical readouts for its DM1 and FSHD siRNA programs, alongside discussion of Arrowhead data as a possible validation of the technology. Bulls see the pipeline as a potential growth driver, while skeptics say early or preclinical results still need to translate into meaningful patient benefit and question the stocks weak price action.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJTs slide to record lows is being discussed alongside expectations of Republican losses in the midterms and declining confidence in Trump, with many traders blaming the stocks political association and questioning the companys business value. The conversation is predominantly bearish, though some traders see a possible short-term bounce.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports Phase 2 trial of RAP-219 in bipolar mania met its primary and secondary endpoints, driving a sharp burst of bullish attention. Traders are divided over whether the modest placebo-adjusted improvement and safety and discontinuation concerns make the result less compelling, with some viewing it as proof of concept and others expecting the rally to fade.

SPDR Series Trust - State Street SPDR S&P Biotech ETF

SPDR S&P Biotech ETF

A broad biotech-sector rebound is driving attention, with traders describing XBI as breaking out after a sharp pullback and citing renewed buying and possible rotation into biotech. Bulls see a recovery taking hold, while skeptics warn the bounce could fade amid rate and other macro headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Norwegians improved Q3 outlook and reaffirmed 2026 forecast, alongside Carnivals strong results and raised guidance, have lifted cruise-sector sentiment and sparked a move in NCLH. Traders are optimistic about a catch-up rally and possible short covering, while some remain cautious about NCLH lagging peers and ongoing fuel-cost and management concerns.

Norwegian Cruise Line (NCLH) Surpasses Market Returns: Some Facts Worth Knowing

The latest trading day saw Norwegian Cruise Line (NCLH) settling at $15.24, representing a +1.26% change from its previous close.

Will Norwegian Cruise Line (NCLH) Beat Estimates Again in Its Next Earnings Report?

Norwegian Cruise Line (NCLH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Can Carnival's AI Push Accelerate Margin Expansion Through 2029?

CCL is using AI, automation and vessel management to lift revenues and efficiency as PROPEL targets margin expansion through 2029.

RCL Stock Rises 12% in a Month: Should You Buy Now or Hold Steady?

Royal Caribbean's strong demand, higher guest spending and loyalty growth bode well. Yet premium valuation and geopolitical pressures warrant caution.

Norwegian Cruise Line Holdings Ltd. (NCLH) Is a Trending Stock: Facts to Know Before Betting on It

Norwegian Cruise Line (NCLH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Norwegian Cruise Line (NCLH) Suffers a Larger Drop Than the General Market: Key Insights

Norwegian Cruise Line (NCLH) reached $15.35 at the closing of the latest trading day, reflecting a -1.41% change compared to its last close.

Can Carnival's 0.5% Capacity Growth Support Higher FY27 Yields?

CCL is leveraging record advance bookings and strong demand to drive higher yields in FY27, while Caribbean competition and loyalty-related headwinds ail.

Royal Caribbean's Repeat Guests Spend More: Can Loyalty Drive Growth?

RCL's repeat guests spend 20% to 25% more, while loyalty programs and digital engagement aim to drive bookings and onboard revenue growth.

Should You Buy, Sell or Hold Carnival Stock Post Q3 Earnings?

CCL's 18.1% post-earnings rally, record bookings and discounted valuation boost its appeal, but fuel costs and capacity pressures warrant caution.

Can Royal Caribbean's Record 2027 Pricing Sustain Its Growth Run?

RCL enters 2027 with record pricing, strong bookings, new ships and deeper loyalty engagement, supporting continued growth momentum.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

RCL Stock Sees Best Day In Two Months — JPMorgan, Citi Bullish On Royal Caribbean's Sandals Partnership

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Royal Caribbean is purchasing a half-share in Sandals and Beaches Resorts for around $3 billion, valuing the resort operator at $6 billion.&nbsp;</li><li>Citi analyst James Hardiman placed Royal Caribbean on a 90-day Catalyst Watch, citing potential competitive advantages that could widen its edge over cruise sector peers.&nbsp;</li><li>JPMorgan hiked price target on RCL stock to $394 from $345, a near 71% upside from Wednesday’s closing price.</li></ul>Royal Caribbean Group’s (RCL) move to buy a 50% stake in Sandals Resorts could fundamentally reshape the leisure travel sector, turning the ocean cruise operator into a land-and-sea vacation powerhouse, according to a Citi Research report.In a note to investors, viewed by Seeking Alpha, Citi analyst James Hardiman placed a 90-day positive Catalyst Watch on Buy-rated Royal Caribbean Group. The optimism follows Royal Caribbean’s announcement that it will invest about $3 billion to secure a half-ownership stake in Sandals Resorts International, a deal valuing the resort enterprise at roughly $6 billion.Following the news, Royal Caribbean shares added nearly 4% on Thursday, outpacing rivals such as Carnival Corp. (CCL) and Norwegian Cruise Line Holdings (NCLH).<h2 class="st-heading-2">Transforming From Cruise Operator To Vacation Ecosystem</h2>Citi analysts view the transaction as more than a simple entry into land-based hospitality. Hardiman noted that adding Sandals and Beaches Resorts creates a cross-category vacation network that traditional competitors will struggle to match.By tying together its ocean fleet, incoming river cruise line, private islands, such as Perfect Day at CocoCay, and now luxury land-based resorts, Royal Caribbean is attempting to shift traveler decision-making. Instead of consumers choosing between individual cruise lines, they may soon choose between comprehensive travel ecosystems.While company executives highlighted Sandals' immediate strengths, including strong brand loyalty and solid profit margins, Hardiman stressed that the true value lies in what Sandals brings to Royal Caribbean's broader network.Moreover, JPMorgan also hikes its price target on RCL stock to $394 from $345, a near 71% upside from Wednesday’s closing price.&nbsp;<h2 class="st-heading-2">The Royal Caribbean And Sandals Partnership Details</h2>Under the agreement, Royal Caribbean Group will acquire a 50% equity stake in Sandals Resorts International, bringing Sandals and Beaches Resorts under its broader vacation umbrella.The Stewart family, who founded Sandals Resorts more than four decades ago, will retain their half-ownership alongside operational continuity for the distinctive Caribbean identity of the brands. The transaction is slated to officially close in early 2027, subject to regulatory approvals.While existing reservations, travel advisor commissions, and booking platforms remain unchanged in the near term, Royal Caribbean plans to connect Sandals into its unified loyalty platform over time.The deal adds all-inclusive land resorts to a corporate portfolio that already includes Royal Caribbean International, Celebrity Cruises, Silversea, and the planned Celebrity River Cruises line launching in 2027.<h2 class="st-heading-2">RCL Stock: Retail View&nbsp;</h2>Retail sentiment on Stocktwits was ‘bullish’ with ‘high’ message volumes.&nbsp; <a href="https://stocktwits.com/symbol/RCL">RCL stock</a> has lost about 16% year-to-date.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Passengers are seen crowding the upper deck as MS Independence of the Seas sails the Tagus River on May 28, 2025, in Lisbon, Portugal.

Citi Research has placed Royal Caribbean Group on a 90-day positive Catalyst Watch following the cruise giant's $3-billion acquisition of a 50% stake in Sandals Resorts.

RCL Stock Sees Best Day In Two Months — JPMorgan, Citi Bullish On Royal Caribbean's Sandals Partnership As A Positive Catalyst

Carnival Corp

Royal Caribbean Group

Double beat (rev + EPS)

Revenue beat, EPS miss

EPS beat, revenue miss

Double miss

SpaceX ($SPCX) reports earnings after the close today. What do you expect?

Stocktwits

SpaceX

) reports earnings after the close today. What do you expect?

Stocktwits Polls

Traders are intensely focused on the critical $16 resistance level as a key breakout point heading into earnings.

Investors are largely holding their positions and ignoring daily volatility while anticipating positive catalysts in upcoming earnings reports.

Market sentiment remains heavily influenced by fluctuating oil prices and their potential impact on cruise line operational costs.

Current Price	$15.77
Prev Close	$15.24
Open	$15.19
Dividend Yield	0.00%
50-Day Moving Average	$15.79
Beta	1.81
Avg. Volume	19.1M
PE Ratio	9.63

52-Week High	$25.13
52-Week Low	$13.63
Market Capitalization	$7B
EPS (Annual)	$0.9151
Price to Book	2.72
Revenue Per Employee	$220,844.76

Feed

News

Sentiment

Earnings

Fundamentals

Info

NCLH Fundamentals